PEX PharmaSequence is a market research and consulting firm operating on the healthcare market. In our projects we are concerned exclusively with commercial aspects of our clients’ activities. We do not perform clinical trials.
We take extraordinary care to ensure that personal data of participants of our projects is duly protected and is not processed by any unauthorized parties. We base our procedures on the 29th August 1997 act on personal data protection, Ministry of Administration’s regulation from 29th April 2004 regarding documentation, organizational and technical conditions in processing personal data, as well as the ICC/ESOMAR code of conduct.
In the course of implementation of our projects we conduct adverse effects monitoring. We are competent legally and operationally, we also have a dedicated team that ensures the effective flow of information about adverse effects to the project’s commissioners.